Q32 Bio (QTTB) Cash from Investing Activities Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 350,100.00% |
| Sep 30, 2024 | 994,300.00% |
| Jun 30, 2024 | 988,700.00% |
| Mar 31, 2024 | 2,040.00% |
| Sep 30, 2023 | 100.00% |
| Jun 30, 2023 | 100.00% |
| Mar 31, 2023 | -100.00% |
| Dec 31, 2022 | -58.79% |
| Sep 30, 2022 | -2,492.09% |
| Jun 30, 2022 | -201.13% |
| Mar 31, 2022 | 297.47% |
| Dec 31, 2021 | 4,671.83% |
| Sep 30, 2021 | -88.35% |
| Jun 30, 2021 | -126.41% |
| Mar 31, 2021 | -174.12% |
| Dec 31, 2020 | 95.23% |
| Sep 30, 2020 | 395.68% |
| Jun 30, 2020 | 235.79% |
| Mar 31, 2020 | 484.72% |
| Dec 31, 2019 | -296.30% |
| Sep 30, 2019 | 70.97% |
| Jun 30, 2019 | 58.98% |
| Mar 31, 2019 | 196.19% |
| Dec 31, 2018 | 112.77% |
| Sep 30, 2018 | -15,008.27% |
| Jun 30, 2018 | -19,628.54% |
| Mar 31, 2018 | 882.62% |